Nonrulemaking

Patent Term Application for ZIIHERA® (zanidatamab-hrii), Patent No. 10,000,576

🏛 Food and Drug Administration (FDA)FDA-2025-E-0372

Intellectual Property

Documents

2

Total comments

0

all analyzed

Comment status

Closed

Last activity

—

In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 2 Notice 1 Other 1

Notice· Apr 3, 2026
Determination of Regulatory Review Period for Purposes of Patent Extension; ZIIHERA→
Closed on Jun 3, 2026